ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Tempest Therpeutics Inc

Tempest Therpeutics Inc (TPST)

0.8415
0.0005
(0.06%)
終値: 12月31日 6:00AM
0.8412
-0.0003
( -0.04% )
取引時間後: 6:15AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.8412
買値
0.8399
売値
0.8412
出来高
1,364,541
0.7864 日の範囲 0.87405
0.6986 52 週間の範囲 6.00
時価総額
前日終値
0.841
始値
0.8199
最終取引時間
06:15:50
財務取引量
US$ 1,139,929
VWAP
0.835394
平均取引量 (3 か月)
3,894,029
発行済株式数
43,642,072
配当利回り
-
PER
-1.27
1 株当たり利益 (EPS)
-0.68
歳入
-
純利益
-29.49M

Tempest Therpeutics Inc について

Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Tempest Therpeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TPST. The last closing price for Tempest Therpeutics was US$0.84. Over the last year, Tempest Therpeutics shares have traded in a share price range of US$ 0.6986 to US$ 6.00.

Tempest Therpeutics currently has 43,642,072 shares in issue. The market capitalisation of Tempest Therpeutics is US$36.70 million. Tempest Therpeutics has a price to earnings ratio (PE ratio) of -1.27.

TPST 最新ニュース

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference

BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Building upon a successful end-of-Phase 2 meeting, received FDA “Study May Proceed” letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced...

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.107214.60490463220.7340.920.7221635210.85493056CS
4-0.1088-11.45263157890.951.03810.698617272650.83099166CS
12-0.5488-39.48201438851.391.590.698638940291.03636642CS
26-1.3088-60.87441860472.152.310.698630010741.22770921CS
52-3.5088-80.66206896554.3560.698620276611.79675522CS
156-4.3688-83.85412667955.219.770.1716674024.22344969CS
260-12.9688-93.908761766813.81410.1714729164.73021122CS

TPST - Frequently Asked Questions (FAQ)

What is the current Tempest Therpeutics share price?
The current share price of Tempest Therpeutics is US$ 0.8412
How many Tempest Therpeutics shares are in issue?
Tempest Therpeutics has 43,642,072 shares in issue
What is the market cap of Tempest Therpeutics?
The market capitalisation of Tempest Therpeutics is USD 36.7M
What is the 1 year trading range for Tempest Therpeutics share price?
Tempest Therpeutics has traded in the range of US$ 0.6986 to US$ 6.00 during the past year
What is the PE ratio of Tempest Therpeutics?
The price to earnings ratio of Tempest Therpeutics is -1.27
What is the reporting currency for Tempest Therpeutics?
Tempest Therpeutics reports financial results in USD
What is the latest annual profit for Tempest Therpeutics?
The latest annual profit of Tempest Therpeutics is USD -29.49M
What is the registered address of Tempest Therpeutics?
The registered address for Tempest Therpeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Tempest Therpeutics website address?
The website address for Tempest Therpeutics is www.tempesttx.com
Which industry sector does Tempest Therpeutics operate in?
Tempest Therpeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AIEVThunder Power Holdings Inc
US$ 0.6263
(37.23%)
529.56k
BDMDBaird Medical Investment Holdings Ltd
US$ 1.46
(36.45%)
18.28k
MARXMars Acquisition Corporation
US$ 11.72
(33.18%)
3.46k
ICGIntchains Group Ltd
US$ 3.92
(15.63%)
101.14k
EYENEyenovia Inc
US$ 0.1282
(13.96%)
9.29M
WATTEnergous Corporation
US$ 2.31
(-14.44%)
3.45M
VINCVincerx Inc
US$ 0.29
(-10.58%)
418.48k
MYNAMynaric AG
US$ 0.851
(-9.35%)
57.16k
FAASDigiAsia Corporation
US$ 1.03
(-8.85%)
17.32k
OTRKOntrak Inc
US$ 1.8212
(-8.66%)
1.74k
EYENEyenovia Inc
US$ 0.1282
(13.96%)
9.29M
GERNGeron Corp
US$ 3.41
(0.59%)
7.74M
TLTiShares 20 plus Year Treasury Bond
US$ 87.92
(0.12%)
6.84M
ACADAcadia Pharmaceuticals Inc
US$ 16.69
(0.00%)
5.02M
IGFiShares Global Infrastructure
US$ 52.273
(-0.05%)
4.54M

TPST Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock